{"title":"使用XGBoost模型检测事件相关电位作为重性抑郁症的生物标志物","authors":"Yuhang Pan, Jing Jie, Ming Yin","doi":"10.1016/j.bspc.2025.107879","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective:</h3><div>To evaluate biomarkers that assist in the identification of electroencephalography signals in patients with depression, utilizing an ensemble learning model.</div></div><div><h3>Methods:</h3><div>XGBoost ensemble model was trained and tested to classify patients with major depressive disorder (MDD) (n=24) and healthy controls (HCs) (n=29) from the multi-modal open dataset for mental-disorder analysis. Based on event-related potentials (ERPs) to emotional-neutral face pairs (Happy-Neutral, Sad-Neutral, Fear-Neutral) as stimuli, we segmented six conditions: 3 emotional cues, dots (happy, sad, and fear) and applied the FisherScore feature selection method to select the waveform features with high mutual information. Overall, 80% of the data was selected to establish the XGBoost model with five-fold cross-validation.</div></div><div><h3>Results:</h3><div>We identified happy, sad and fear conditions with waveform features (170–230 s) to distinguish patients with depression. The proposed XGBoost model had a comprehensive accuracy, precision, recall, F1-score, and area under curve of 99.52%, 99.39%, 99.67%, 99.52%, and 99.98% for the ERPs. Furthermore, our experimental results indicated that suppression of the amplitude of negative emotional cues could be used to recognize depression, which was predominantly over the frontal lobe and frontal poles regions. The response latency of ERP signals contributed significantly to distinguishing between HCs and patients with MDD.</div></div><div><h3>Conclusion:</h3><div>An ensemble learning system for classification using the XGBoost and feature selection using FisherScore has the potential to be used in clinical prediction of depressive symptoms in patients with MDD.</div></div><div><h3>Significance:</h3><div>The discovery of ERPs as a biomarker has important clinical implications for exploring the pathogenesis behind MDD.</div></div>","PeriodicalId":55362,"journal":{"name":"Biomedical Signal Processing and Control","volume":"108 ","pages":"Article 107879"},"PeriodicalIF":4.9000,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Detection of event-related potentials as a biomarker in major depressive disorder using an XGBoost model\",\"authors\":\"Yuhang Pan, Jing Jie, Ming Yin\",\"doi\":\"10.1016/j.bspc.2025.107879\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective:</h3><div>To evaluate biomarkers that assist in the identification of electroencephalography signals in patients with depression, utilizing an ensemble learning model.</div></div><div><h3>Methods:</h3><div>XGBoost ensemble model was trained and tested to classify patients with major depressive disorder (MDD) (n=24) and healthy controls (HCs) (n=29) from the multi-modal open dataset for mental-disorder analysis. Based on event-related potentials (ERPs) to emotional-neutral face pairs (Happy-Neutral, Sad-Neutral, Fear-Neutral) as stimuli, we segmented six conditions: 3 emotional cues, dots (happy, sad, and fear) and applied the FisherScore feature selection method to select the waveform features with high mutual information. Overall, 80% of the data was selected to establish the XGBoost model with five-fold cross-validation.</div></div><div><h3>Results:</h3><div>We identified happy, sad and fear conditions with waveform features (170–230 s) to distinguish patients with depression. The proposed XGBoost model had a comprehensive accuracy, precision, recall, F1-score, and area under curve of 99.52%, 99.39%, 99.67%, 99.52%, and 99.98% for the ERPs. Furthermore, our experimental results indicated that suppression of the amplitude of negative emotional cues could be used to recognize depression, which was predominantly over the frontal lobe and frontal poles regions. The response latency of ERP signals contributed significantly to distinguishing between HCs and patients with MDD.</div></div><div><h3>Conclusion:</h3><div>An ensemble learning system for classification using the XGBoost and feature selection using FisherScore has the potential to be used in clinical prediction of depressive symptoms in patients with MDD.</div></div><div><h3>Significance:</h3><div>The discovery of ERPs as a biomarker has important clinical implications for exploring the pathogenesis behind MDD.</div></div>\",\"PeriodicalId\":55362,\"journal\":{\"name\":\"Biomedical Signal Processing and Control\",\"volume\":\"108 \",\"pages\":\"Article 107879\"},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2025-04-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biomedical Signal Processing and Control\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1746809425003908\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical Signal Processing and Control","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1746809425003908","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
Detection of event-related potentials as a biomarker in major depressive disorder using an XGBoost model
Objective:
To evaluate biomarkers that assist in the identification of electroencephalography signals in patients with depression, utilizing an ensemble learning model.
Methods:
XGBoost ensemble model was trained and tested to classify patients with major depressive disorder (MDD) (n=24) and healthy controls (HCs) (n=29) from the multi-modal open dataset for mental-disorder analysis. Based on event-related potentials (ERPs) to emotional-neutral face pairs (Happy-Neutral, Sad-Neutral, Fear-Neutral) as stimuli, we segmented six conditions: 3 emotional cues, dots (happy, sad, and fear) and applied the FisherScore feature selection method to select the waveform features with high mutual information. Overall, 80% of the data was selected to establish the XGBoost model with five-fold cross-validation.
Results:
We identified happy, sad and fear conditions with waveform features (170–230 s) to distinguish patients with depression. The proposed XGBoost model had a comprehensive accuracy, precision, recall, F1-score, and area under curve of 99.52%, 99.39%, 99.67%, 99.52%, and 99.98% for the ERPs. Furthermore, our experimental results indicated that suppression of the amplitude of negative emotional cues could be used to recognize depression, which was predominantly over the frontal lobe and frontal poles regions. The response latency of ERP signals contributed significantly to distinguishing between HCs and patients with MDD.
Conclusion:
An ensemble learning system for classification using the XGBoost and feature selection using FisherScore has the potential to be used in clinical prediction of depressive symptoms in patients with MDD.
Significance:
The discovery of ERPs as a biomarker has important clinical implications for exploring the pathogenesis behind MDD.
期刊介绍:
Biomedical Signal Processing and Control aims to provide a cross-disciplinary international forum for the interchange of information on research in the measurement and analysis of signals and images in clinical medicine and the biological sciences. Emphasis is placed on contributions dealing with the practical, applications-led research on the use of methods and devices in clinical diagnosis, patient monitoring and management.
Biomedical Signal Processing and Control reflects the main areas in which these methods are being used and developed at the interface of both engineering and clinical science. The scope of the journal is defined to include relevant review papers, technical notes, short communications and letters. Tutorial papers and special issues will also be published.